KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Accumulated Expenses (2016 - 2026)

Medpace Holdings filings provide 12 years of Accumulated Expenses readings, the most recent being $406.1 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 41.93% to $406.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $406.1 million, a 41.93% increase, with the full-year FY2025 number at $408.4 million, up 32.67% from a year prior.
  • Accumulated Expenses hit $406.1 million in Q1 2026 for Medpace Holdings, down from $408.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $408.4 million in Q4 2025 to a low of $44.7 million in Q1 2022.
  • Median Accumulated Expenses over the past 5 years was $286.1 million (2025), compared with a mean of $263.2 million.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 350.51% in 2023 and later rose 5.07% in 2024.
  • Medpace Holdings' Accumulated Expenses stood at $210.1 million in 2022, then surged by 39.42% to $293.0 million in 2023, then grew by 5.07% to $307.8 million in 2024, then skyrocketed by 32.67% to $408.4 million in 2025, then dropped by 0.57% to $406.1 million in 2026.
  • The last three reported values for Accumulated Expenses were $406.1 million (Q1 2026), $408.4 million (Q4 2025), and $368.7 million (Q3 2025) per Business Quant data.